Tagged Articles

dislocation 52 articles

Labor-inducing drug can reduce pain with IUD insertion

Vaginal administration of a misoprostol tablet four hours before IUD insertion reduces the difficulty and pain associated with IUD insertion in women who have never been pregnant, according to a new study. Misoprostol is a medicine that softens and dilates the cervix, causes uterine contractions and, in pregnant women, induces labor. It is used to treat gastric ulcers caused by non-steroidal anti-inflammatory drugs, to treat missed miscarriage, to induce labor and induce abortion. The study ranged from 2009 to 2011 and involved 179 women who had never been pregnant. Women were randomly given misoprostol or placebo vaginally four hours prior ... Read More

Judge upholds $8.3-million verdict against DePuy in first ASR hip implant trial

A Los Angeles Superior Court judge has upheld an $8.3-million verdict in favor of plaintiff Loren “Bill” Kransky, the first plaintiff to have his case tried against DePuy Orthopedics over its faulty ASR hip implants. DePuy and parent company Johnson & Johnson asked Judge J. Stephen Czuleger to overturn the jury’s March decision awarding Mr. Kransky, a retired South Dakota prison guard, $8.3 million for severe and extensive injuries that he alleged stemmed from a DePuy ASR metal-on-metal hip implant. Judge Czuleger said that sufficient evidence had been demonstrated that DePuy’s ASR hips were defectively designed. Mr. Kransky, 66, had ... Read More

Judge moves second DePuy hip bellwether trial to September

A federal judge overseeing multidistrict litigation (MDL) involving all-metal ASR hip implants made by DePuy Orthopedics has moved the second bellwether trial from June to September. Judge David Katz, who is presiding over thousands of DePuy lawsuits consolidated in U.S. District Court for the Northern District of Ohio, filed a trial order on April 22 pushing back the case brought by plaintiff Ann McCracken, a 57-year-old single mother and business owner. Proceedings for the first bellwether case were scheduled to start June 3. The U.S. judicial system uses bellwether trials to represent the larger body of litigation when the number ... Read More

DePuy seeks to overturn $8.26 million jury award in first ASR hip trial

Johnson & Johnson and its orthopedics unit DePuy seek to overturn a Los Angeles jury’s decision to award $8.26 million to a plaintiff for injuries he received from a metal-on-metal DePuy ASR hip implant. The companies claim that the jury’s findings were inconsistent with court instructions about defective product design and adequate warning of the device’s risk. The verdict DePuy and its parent company want to overturn concluded the first U.S. trial involving defective ASR hip implants. Plaintiff Loren Kransky sued DePuy and affiliated companies after the ASR device he had implanted in his left hip in 2007 failed and ... Read More

DePuy’s ASR hip implant caused plaintiff’s bone decay, surgeon tells jury

An orthopedic surgeon testifying on behalf of a woman who alleges she was injured by ASR metal hip implants manufactured by DePuy Orthopedics told jurors in the Circuit Court of Cook County, Illinois, that metal debris from the hip devices “absolutely” caused the plaintiff to suffer from bone decay. DePuy is a subsidiary of Johnson & Johnson. Surgeon Tony Nargol, who has warned about the dangers of metal-on-metal hip implants such as DePuy’s ASR devices, particularly to women, told jurors that plaintiff Carol Strum’s calcar bone had been “eaten away” near the ASR hip device she had implanted in in ... Read More

British MPs call for criminal inquiry into toxic DePuy hip implants

British MPs have called for an investigation into DePuy Orthopaedics after testimony from a U.S. court case revealed that the medical device company continued to sell defective artificial hip implants despite knowing for at least three years they were toxic to patients. DePuy, a subsidiary of Johnson & Johnson, recalled the ASR hip replacement system and hip resurfacing system after mounting reports that the device was failing at a higher than expected rate. The recall affected an estimated 93,000 people worldwide. The DePuy device was made to be more durable with all-metal parts, as opposed to plastic or ceramic parts ... Read More

Hip implant failure 29 percent higher in women, new study finds

A new study of more than 35,100 patients who were surgically implanted with artificial hip devices reveals that women are much more likely than men to require revision surgery within the first three years to correct problems with the implant. The research, published in JAMA Internal Medicine, was funded by the U.S. Food and Drug Administration (FDA) and comes amid a torrent of lawsuits against Johnson & Johnson and its orthopedic device unit DePuy alleging the company’s ASR all-metal hip devices caused serious, sometimes catastrophic, injuries in patients. Of the 35,140 total hip anthroplasty (THA) patients studied, female subjects were ... Read More

Emails presented in DePuy trial show marketer’s concerns over ASR hip implant safety

Internal communications among DePuy executives discussing how to handle metal-on-metal ASR hip problems were presented to jurors hearing the first of several thousand personal-injury lawsuits involving the faulty devices to go to trial. DePuy is a subsidiary of Johnson & Johnson. According to the records presented, on September 18, 2009, Paul Berman, DePuy’s director of hip marketing, sent one of many emails to company officials warning that the metal-on-metal hip devices should be recalled given the alarming number of reports that the devices were failing. Mr. Berman wrote that he wanted to “reiterate my concerns” about the safety of the ... Read More

Testimony in first DePuy trial indicates company failed to act on ASR hip warnings

Court documents and the recent testimony given by DePuy officials during the first ASR metal hip case to go to trial indicate the company took very little action, if any, to warn prospective patients about the serious risks its all-metal hip implants posed. DePuy Orthopedics, a division of the Johnson & Johnson health care conglomerate, started selling its ASR Acetabular and Hip Resurfacing Systems in 2003 after the devices were fast-tracked through the U.S. Food and Drug Administration’s approval process. By 2005, DePuy began receiving complaints about the all-metal devices, which were designed to outlast conventional hip implants made with ... Read More

First DePuy hip trial underway in Los Angeles

The first of several thousand personal-injury lawsuits accusing Johnson & Johnson of knowingly making and selling faulty metal-on-metal hip implants commenced Friday in California Superior Court in Los Angeles. Plaintiff Loren Kransky, a former North Dakota prison guard, received metal-on-metal hip implants made by Johnson & Johnson’s DePuy Orthopedics division in 2007 to relieve arthritis pain. But not long afterward, Mr. Kransky, 64, began experiencing many of the complications reported by others who received DePuy ASR implants: pain, swelling, difficulty walking, and a number of symptoms related to metal poisoning. On the first day of the trial, the plaintiff’s lawyer ... Read More